Wednesday, July 30, 2025

Numinus Wellness To Collaborate With MAPS On Proposed MDMA-Assisted Psychotherapy Trials

Numinus Wellness (TSXV: NUMI) this morning announced that it has entered into an arrangement with a subsidiary of the Multidisciplinary Association for Psychedelic Studies, also known as MAPS, to collaborate on a clinical trial that uses MDMA. The collaboration will see the duo collaborate for Health Canada approval to conduct an MDMA-assisted psychotherapy for PTSD through clinical trials.

Defined as being a single-arm, open-label, compassionate access trial, the purpose of the trial is to push towards increasing the accessibility of MDMA-based treatment options for those suffering from PTSD. The proposed program will see Numinus’ Vancouver clinic provide psychotherapy assisted by the use of MDMA to an initial group of twenty people that currently suffer from PTSD.

Data is to be collected on the outcome of the psychotherapy, along with safety data, which is to be provided to Health Canada. The trials are to be conducted under MAPS’ PTSD treatment protocol, with all staff, therapists and physicians to be trained under this protocol prior to approval by the regulatory agency.

Though this treatment is still investigational, if approval is granted through the regulatory pathway this collaboration will bolster our shared goal of addressing the enormous — and growing — need for improved proven treatments for people suffering from PTSD.

Amy Emerson, CEO of MAPS PBC

The clinical trial is to be the first of its kind in Canada. A timeline for the program has not yet been provided.

Numinus Wellness last traded at $0.68 on the TSX Venture.


Information for this briefing was found via Sedar and Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Gold’s Bull Run May Just Be Getting Started! | Peter Grandich

Tariffs Spark New Race for Critical Metals | Rob McEwen

Antimony Resources: The Bald Hill Project

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

Numinus Wellness Walks From Acquisition Of MedBright AI

Numinus Wellness (TSX: NUMI) has walked away from a plan to add artificial intelligence assets...

Monday, August 12, 2024, 10:08:35 AM

Numinus Wellness To Acquire Mindspace Psychology Services Of Montreal

Numinus Wellness (TSXV: NUMI) is acquiring that of Mindspace Psychology Services, whom operates as Mindspace...

Tuesday, December 15, 2020, 08:34:20 AM

Numinus Sees Integrated VC, MAPS Lead $6.0 Million Funding Round

Numinus Wellness (TSX: NUMI) has received a major vote of confidence, announcing last night that...

Friday, February 2, 2024, 09:00:02 AM

Numinus Wellness To Conduct $10.0 Million Bought Deal

Numinus Wellness (TSXV: NUMI) evidently is seeing strong investor demand, with the psychedelics firm this...

Monday, December 7, 2020, 07:38:26 AM

Numinus Sells Utah Clinics For US$3.53 Million

Numinus Wellness (TSX: NUMI) is disposing of its US-based clinics in a transaction that is...

Friday, November 15, 2024, 08:03:39 AM